Cannon Global Investment Management, LLC
13F Reported Value
ⓘ$51.2M
incl. option notional
Equity Holdings
ⓘ$41.3M
Option Notional
ⓘ$9.9M
$7.5M puts / $2.4M calls
Holdings
82
Latest Filing
2026-03-31
Filing Quarter
Q1 2026
Portfolio Overview
Cannon Global Investment Management, LLC disclosed 82 positions worth $51.2M in its Form 13F-HR for Q1 2026 — $41.3M in common stock plus $9.9M of put/call option positions (reported at underlying notional value, not premium at risk), led by $QQQ (INVESCO QQQ TRUST, SERIES 1) puts, followed by $NSC and $SUI. During the quarter the fund opened 50 new positions and exited 27 — including a new stake in $QQQ and a full exit from $WBD. The portfolio is most concentrated in Healthcare (25.8% of disclosed assets). All figures are sourced directly from Cannon Global Investment Management, LLC’s Form 13F-HR filing with the SEC under CIK 1844427.
AI Fund Analysis
DiversifyingSector Allocation
AUM History
Top Equity Holdings by Value
Option Positions
13F rules report options at the value of the underlying shares (notional) — not the premium paid or capital at risk. Shown separately from the equity sleeve above.
Quarterly Activity — Q1 2026
Click any card to unlockTop Holdings
- $7.5M13,000 sh
- 70.8#289
Quality
$2.0M7,000 sh - 44.4#1,773
Quality
$1.5M11,900 sh - 48.4
Quality
$1.4M5,100 sh - —
Quality
$1.4M34,400 sh - $1.3M25,000 sh
- 72.4
Quality
$1.3M16,300 sh - —
Quality
$1.2M118,000 sh - 71.1
Quality
$1.2M6,000 sh - 25.4
Quality
$1.0M2,000 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| — | $7.5M | 13,000 | |
| 70.8#289 | $2.0M | 7,000 | |
| 44.4#1,773 | $1.5M | 11,900 | |
| 48.4 | $1.4M | 5,100 | |
| — | $1.4M | 34,400 | |
| — | $1.3M | 25,000 | |
| 72.4 | $1.3M | 16,300 | |
| — | $1.2M | 118,000 | |
| 71.1 | $1.2M | 6,000 | |
| 25.4 | $1.0M | 2,000 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Cannon Global Investment Management, LLC's 82 positions.
Showing top 10 of 82 holdings.
Sector Allocation
Healthcare
$10.7M
Technology
$8.5M
Financials
$8.4M
Industrials
$4.8M
Consumer Discretionary
$2.0M
Communication Services
$1.9M
Real Estate
$1.6M
Energy
$1.4M
Full Holdings — Cannon Global Investment Management, LLC (Q1 2026)
All 82 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | INVESCO QQQ TRUST, SERIES 1 | $7.5M | — | NEW | — | |
| 2 | NORFOLK SOUTHERN CORP | $2.0M | 4.9% | +13% | 70.8 | |
| 3 | SUN COMMUNITIES INC | $1.5M | 3.6% | NEW | 44.4 | |
| 4 | Cheniere Energy, Inc. | $1.4M | 3.5% | -7% | 48.4 | |
| 5 | QIAGEN N.V. | $1.4M | 3.3% | NEW | — | |
| 6 | Terns Pharmaceuticals, Inc. | $1.3M | — | NEW | — | |
| 7 | Zoom Communications, Inc. | $1.3M | 3.2% | +23% | 72.4 | |
| 8 | Cantor Equity Partners I, Inc. | $1.2M | 3.0% | +15% | — | |
| 9 | ELECTRONIC ARTS INC. | $1.2M | 3.0% | +445% | 71.1 | |
| 10 | MADRIGAL PHARMACEUTICALS, INC. | $1.0M | — | NEW | 25.4 | |
| 11 | Fox Corp | $1.0M | 2.5% | +16% | 65.1 | |
| 12 | Marvell Technology, Inc. | $970,690 | 2.4% | -41% | 77.3 | |
| 13 | Cantor Equity Partners II, Inc. | $958,320 | 2.3% | +126% | — | |
| 14 | Renatus Tactical Acquisition Corp I | $952,956 | 2.3% | +22% | — | |
| 15 | SS&C Technologies Holdings Inc | $945,980 | 2.3% | +63% | 67.2 | |
| 16 | Cantor Equity Partners III, Inc. | $863,978 | 2.1% | +13% | — | |
| 17 | Revolution Medicines, Inc. | $826,625 | 2.0% | NEW | — | |
| 18 | CHART INDUSTRIES INC | $806,325 | 1.9% | +18% | 60.6 | |
| 19 | ALNYLAM PHARMACEUTICALS, INC. | $794,088 | 1.9% | NEW | 60.9 | |
| 20 | Cantor Equity Partners IV, Inc. | $771,383 | 1.9% | +16% | — | |
| 21 | POPULAR, INC. | $764,769 | 1.9% | +119% | — | |
| 22 | ESTABLISHMENT LABS HOLDINGS INC. | $738,140 | 1.8% | NEW | 26.7 | |
| 23 | Cellebrite DI Ltd. | $723,450 | 1.8% | NEW | — | |
| 24 | Ferguson Enterprises Inc. /DE/ | $699,780 | 1.7% | NEW | 58.9 | |
| 25 | Abivax S.A. | $668,100 | 1.6% | +175% | — | |
| 26 | JFrog Ltd | $661,713 | 1.6% | NEW | — | |
| 27 | UNIFIRST CORP | $628,975 | 1.5% | -63% | 48.4 | |
| 28 | Warner Bros. Discovery, Inc. | $617,850 | 1.5% | -61% | 42.1 | |
| 29 | Hinge Health, Inc. | $613,104 | 1.5% | NEW | 44.9 | |
| 30 | Hennessy Capital Investment Corp. VII | $600,300 | 1.4% | +14% | — | |
| 31 | Chime Financial, Inc. | $580,705 | 1.4% | NEW | 44.8 | |
| 32 | Kiniksa Pharmaceuticals International, plc | $529,650 | 1.3% | NEW | — | |
| 33 | Penumbra Inc | $525,392 | 1.3% | NEW | 69.7 | |
| 34 | JETBLUE AIRWAYS CORP | $521,560 | 1.3% | NEW | 37.6 | |
| 35 | Sunbelt Rentals Holdings, Inc. | $520,720 | 1.3% | NEW | — | |
| 36 | Clearwater Analytics Holdings, Inc. | $494,285 | 1.2% | NEW | 50.2 | |
| 37 | TripAdvisor, Inc. | $492,492 | 1.2% | NEW | 51.5 | |
| 38 | Terns Pharmaceuticals, Inc. | $474,480 | 1.1% | NEW | — | |
| 39 | CytomX Therapeutics, Inc. | $451,670 | 1.1% | NEW | 19.1 | |
| 40 | Dianthus Therapeutics, Inc. /DE/ | $427,992 | 1.0% | NEW | 26.8 | |
| 41 | Berto Acquisition Corp. | $427,425 | 1.0% | +13% | — | |
| 42 | MADRIGAL PHARMACEUTICALS, INC. | $418,776 | 1.0% | +14% | 25.4 | |
| 43 | GFL Environmental Inc. | $417,200 | 1.0% | NEW | — | |
| 44 | MONRO, INC. | $409,020 | 1.0% | NEW | 38.9 | |
| 45 | STAAR SURGICAL CO | $407,660 | 1.0% | +32% | 18 | |
| 46 | iShares Bitcoin Trust ETF | $407,252 | 1.0% | +0% | — | |
| 47 | Lightwave Logic, Inc. | $386,650 | 0.9% | NEW | — | |
| 48 | dLocal Ltd | $361,863 | 0.9% | NEW | — | |
| 49 | Babcock & Wilcox Enterprises, Inc. | $359,905 | 0.9% | NEW | 40 | |
| 50 | — | BARON ETF TR | $356,772 | 0.9% | NEW | — |
| 51 | Avidity Biosciences, Inc. | $335,413 | 0.8% | +73% | 22.3 | |
| 52 | Reddit, Inc. | $323,160 | 0.8% | -25% | 79.3 | |
| 53 | Brighthouse Financial, Inc. | $299,400 | 0.7% | -68% | 54.9 | |
| 54 | Bold Eagle Acquisition Corp. | $298,706 | 0.7% | +13% | — | |
| 55 | UL Solutions Inc. | $291,414 | 0.7% | NEW | 64.1 | |
| 56 | General Fusion Group Ltd. | $279,400 | 0.7% | NEW | — | |
| 57 | Medline Inc. | $267,000 | 0.7% | NEW | — | |
| 58 | HOLOGIC INC | $264,565 | 0.6% | NEW | 62.3 | |
| 59 | Caesars Entertainment, Inc. | $264,300 | 0.6% | NEW | 44.3 | |
| 60 | Theravance Biopharma, Inc. | $260,443 | 0.6% | NEW | 68.9 | |
| 61 | Paymentus Holdings, Inc. | $256,540 | 0.6% | NEW | 70.2 | |
| 62 | BIOCRYST PHARMACEUTICALS INC | $253,232 | 0.6% | NEW | 37.2 | |
| 63 | Damora Therapeutics, Inc. | $240,870 | 0.6% | NEW | — | |
| 64 | NEW ROYAL HOLDCO I INC. | $234,872 | 0.6% | NEW | 33.5 | |
| 65 | BROWN FORMAN CORP | $232,672 | 0.6% | NEW | 65.1 | |
| 66 | GameStop Corp. | $221,570 | 0.5% | +60% | 60.6 | |
| 67 | Invivyd, Inc. | $209,300 | 0.5% | NEW | 25.7 | |
| 68 | Vor Biopharma Inc. | $208,728 | 0.5% | NEW | — | |
| 69 | uniQure N.V. | $199,470 | 0.5% | NEW | — | |
| 70 | Digital Asset Acquisition Corp. | $198,656 | 0.5% | +18% | — | |
| 71 | CRESCENT BIOPHARMA, INC. | $187,374 | 0.5% | NEW | 28 | |
| 72 | GP-Act III Acquisition Corp. | $181,028 | 0.4% | +15% | — | |
| 73 | Contineum Therapeutics, Inc. | $169,780 | 0.4% | NEW | — | |
| 74 | Launch Two Acquisition Corp. | $133,812 | 0.3% | +15% | — | |
| 75 | Ocugen, Inc. | $126,700 | 0.3% | NEW | — | |
| 76 | Kodiak AI, Inc. | $119,368 | 0.3% | NEW | 26.1 | |
| 77 | Kennedy-Wilson Holdings, Inc. | $113,610 | 0.3% | -62% | 29.7 | |
| 78 | Century Therapeutics, Inc. | $110,740 | 0.3% | NEW | 43.5 | |
| 79 | Fossil Group, Inc. | $110,336 | 0.3% | NEW | 28.7 | |
| 80 | Minerva Neurosciences, Inc. | $106,992 | 0.3% | NEW | — | |
| 81 | Orchestra BioMed Holdings, Inc. | $96,080 | 0.2% | NEW | 8.7 | |
| 82 | Gen Digital Inc. | $32,059 | 0.1% | +224% | 67.7 |
New Positions (50)
Exited Positions (27)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Cannon Global Investment Management, LLC including:
Track Cannon Global Investment Management, LLC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Cannon Global Investment Management, LLC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Cannon Global Investment Management, LLC
13F Pro is an AI hedge fund tracker and stock research platform. For Cannon Global Investment Management, LLC (SEC CIK: 1844427), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Cannon Global Investment Management, LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.